Our Recent Pricing Whitepapers
More White Papers
Trust the process of high pharma prices to incentivize innovation and competition
There have been some record-breaking prices set for drugs in recent months. Such high prices for pharmaceuticals are on the minds of many of the payers and clinicians that I speak with during pricing research projects. Such high prices should encourage innovation and competition, and once a specific unmet need has been addressed, the price of treating that specific medical problem will likely come down over time. Continue reading…
The Changing Chinese Consumer: “Doing it their way”
A recent article by The Economist described China as the “next consumption superpower”. On the verge of becoming the second largest consumer economy in the world, it has become a uniquely attractive market for many reasons. However, the evolving Chinese consumer also represents a challenge for international companies. Continue reading…